Spun nanofiber, medical devices, and methods
The present disclosure relates to compounds from which nanofibers can be produced, the resulting nanofibers produced from the compounds, and nanofiber reinforced polymers prepared using the nanofibers and a polymer. The compounds used in forming the nanofibers include chemical linkage moieties that are capable of forming non-covalent bonds with portions of the polymer so as to form the nanofiber reinforced polymers. The nanofiber reinforced polymers are useful as biomaterials in medical devices.
1. A biostable nanofiber formed from a compound of the formula (Formula I):
[(R 2 O) 3 —Si—R 3 ] z —Y—[(R 1 ) m —O x ] q —Y′—[R 3 —Si—(OR 2 ) 3 ] z
where x and z are each independently 0 or 1; m is 1 to 18; q is 1 to 200; R 1 , R 2 and R 3 are each independently an organic group;
and Y and Y′ are selected together from the group consisting of:
—O—(C═O)— for Y and —(C═O)— for Y′ where z=1;
—(NR 4 )—(C═O)—(NH)— for Y and Y′, where z=1, and R 4 is an organic group; and
—N—[CH 2 —(CHOH)—CH 2 —O—R 3 —Si—(OR 2 ) 3 ] 2 for Y and Y′, where z=0;
where the biostable nanofiber is produced by a spinning process.
2. The nanofiber of claim 1 , where the spinning process used to produce the nanofiber is a dry-spinning process.
3. The nanofiber of claim 1 , where the spinning process used to produce the nanofiber is an electrospinning process.
4. The nanofiber of claim 1 , where the nanofiber is used as a reinforcement component with a polymer to form a biomaterial.
5. The nanofiber of claim 4 , where the nanofiber coats the polymer to form the biomaterial.
6. The nanofiber of claim 4 , where the nanofiber is embedded in the polymer to form the biomaterial.
7. The nanofiber of claim 4 , where the nanofiber includes chemical moieties that can non-covalently bond with portions of the polymer.
8. The nanofiber of claim 1 , where the compound of Formula I can form a cross-linked network using a sol-gel process.
9. A medical device prepared from the nanofiber of claim 1 .
10. The nanofiber of claim 1 , where each R 1 and R 3 is independently a (C1-C18)alkylene group, and R 2 is a (C1-C18)alkyl group.
11. A biostable nanofiber reinforced polymer, comprising:
a polymer; and
nanofibers from a compound of the formula (Formula I):
[(R 2 O) 3 —Si—R 3 ] z —Y—[(R 1 ) m —O x ] q —Y′—[R 3 —Si—(OR 2 ) 3 ] z
where x and z are each independently 0 or 1; m is 1 to 18; q is 1 to 200; R 1 , R 2 and R 3 are each independently an organic group;
and Y and Y′ are selected together from the group consisting of:
—O—(C═O)— for Y and —(C═O)— for Y′ where z=1;
—(NR 4 )—(C═O)—(NH)— for Y and Y′, where z=1, and R 4 is an organic group; and
—N—[CH 2 —(CHOH)—CH 2 —O—R 3 —Si—(OR 2 ) 3 ] 2 for Y and Y′, where z=0, where the biostable nanofibers include chemical moieties capable of forming a non-covalent bond with portions of the polymer.
12. The reinforced polymer of claim 11 , where the nanofibers coat a surface of at least a portion of the polymer.
13. The reinforced polymer of claim 12 , where the nanofibers are in a random pattern on the surface of at least a portion of the polymer.
14. The reinforced polymer of claim 11 , where the nanofibers are imbedded in at least a portion of the polymer.
15. The reinforced polymer of claim 14 , where the nanofibers are in a random pattern imbedded in at least a portion of the polymer.
16. The reinforced polymer of claim 11 , where each R 1 and R 3 is independently a (C1-C18)alkylene group, and R 2 is a (C1-C18)alkyl group.
17. The reinforced polymer of claim 11 , where the portions of the polymer that can chemically bond with chemical moieties of the metal-oxide based polymer are selected from the group of a urethane, an ester, an amide, an imide, a urea and a combination thereof.
18. The reinforced polymer of claim 11 , where the polymer is selected from the group polyamide, polyurethane, polyurea, polyurethane-urea, and polyester.
19. A biomaterial comprising the reinforced polymer of claim 11 .
20. A medical device comprising the reinforced polymer of claim 11 .